Hyperpolarized Carbon-13 Alpha-ketoglutarate Imaging in IDH Mutant Glioma

Clinical trial NCT05851378 · COMPLETED

Trial details

NCT number: NCT05851378
Sponsor: Robert Bok, MD, PhD
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Adult Gliomas, Mixed

Start date: 2023-04-11
Primary completion: 2026-01-31
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.